SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-058870
Filing Date
2020-12-30
Accepted
2020-12-30 16:30:13
Documents
6
Period of Report
2020-12-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtvt-8k_20201223.htm 8-K 27721
2 EX-10.1 vtvt-ex101_6.htm EX-10.1 149079
3 GRAPHIC gk3rohselgdu000002.jpg GRAPHIC 651
4 GRAPHIC gk3rohselgdu000004.jpg GRAPHIC 667
5 GRAPHIC gk3rohselgdu000003.jpg GRAPHIC 643
6 GRAPHIC gk3rohselgdu000001.jpg GRAPHIC 643
  Complete submission text file 0001564590-20-058870.txt   182379
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 201426217
SIC: 2834 Pharmaceutical Preparations